Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

What is New in the Pathogenesis and Management of Erythema Nodosum Leprosum.

Bhat RM, Vaidya T. Indian dermatology online journal. 2020; 11 (4) : 482-492.
Download PDF
Publication

Role of Histopathology in Predicting type 1 Lepra Reaction in Borderline Tuberculoid Leprosy.

Sankaran D, Sasidharanpillai S, Ajithkumar K, et al. Indian dermatology online journal. 2020; 11 (4) : 586-589.
Download PDF
Publication

A Masquerading Solitary Skin Lesion: Unusual Presentation of Multibacillary Leprosy with Dermoscopic Assistance in Diagnosis.

Kumar Kansal N, Joshi PP, Dhanta A, et al. Indian dermatology online journal. 2020; 11 (4) : 632-634.
Download PDF
Publication

Macrophage Polarization in Leprosy-HIV Co-infected Patients.

da Silva T, Bittencourt T, de Oliveira A, et al. Frontiers in immunology. 2020;
Download PDF
Publication

Household Contacts of Leprosy Patients in Endemic Areas Display a Specific Innate Immunity Profile.

van Hooij A, Tió-Coma M, Verhard E, et al. Frontiers in immunology. 2020;
Download PDF
Publication

Association of IL-10 Gene Polymorphism With IL-10 Secretion by CD4 and T Regulatory Cells in Human Leprosy.

Tarique M, Naz H, Saini C, et al. Frontiers in immunology. 2020;
Download PDF
Publication

Leprosy Post-Exposure Prophylaxis with Single-dose Rifampicin. Health economic aspects in India

Tiwari A. Erasmus University. Department of Public Health. 2020;
Download PDF
Publication

PERFIL EPIDEMIOLÓGICO DE SUBNOTIFICAÇÃO DA HANSENÍASE NO ESTADO DO TOCANTINS

Feitosa JBBCD, Feitosa JGBCD, Rodrigues YC, et al. Atena Editora. Avanços na Neurologia e na sua Prática Clínica 3. 2020;
Download PDF
Publication

Profil Penderita Morbus Hansen (MH) di Poliklinik Kulit dan Kelamin RSUP Prof. Dr. R. D. Kandou Manado Periode Januari – Desember 2013

Desrina A, Kapantow GM, Kandou RT. e-CliniC. 2020; 8 (2) : 199-202.
Download PDF
Publication

Social representations of a former Colony Hospital: A study of its residents

Passos ÁLV, Araújo LFD. GN1 Genesis Network. Psicologia - Teoria e Prática. 2020;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 334
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD